Prof. Jinbiao Shang 赏金标
Chief Physician, Professor
Thyroid Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, surgery, comprehensive treatment, and postoperative reconstruction for head and neck tumors, including thyroid, salivary gland, hypopharyngeal, laryngeal, oral, and maxillary sinus cancers. Performs scarless endoscopic thyroid surgery.
Dr. Shang holds a master’s degree in oncology and serves as a master’s supervisor at Wenzhou Medical College. Since 1993, Dr. Shang has specialized in head and neck tumor surgery. Training includes head and neck surgical oncology at Centre Hospitalier Lyon Sud, France (2000–2001), and scarless endoscopic thyroid surgery at Overseas Chinese Hospital, Jinan University, Guangzhou (2006). Dr. Shang has published over 20 academic papers, including three first-author SCI articles, and co-edited the textbook Oncology.
Professional roles
- Standing Committee Member and Secretary, Head and Neck Oncology Professional Committee, Zhejiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Shang Jinbiao). Papers usually list the name as Jinbiao Shang or Shang J.
Selected publications
34 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Commun Signal, 2024 (senior author): Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives. PubMed 39342195
- Eur Arch Otorhinolaryngol, 2024 (senior author): Risk factors for parapharyngeal and retropharyngeal metastases in papillary thyroid cancer: a matched case-control study. PubMed 38117306
- Gland Surg, 2022 (senior author): Combined expression of the BRAF(V600E) mutation and PD-L1 in early papillary thyroid carcinoma and its relationship with clinicopathological features and recurrence-a retrospective cohort study. PubMed 36654945
- J Oncol, 2022 (senior author): Circular RNA VANGL1 Facilitates Migration and Invasion of Papillary Thyroid Cancer by Modulating the miR-194/ZEB1/EMT Axis. PubMed 35300347
- Ann Transl Med, 2021 (senior author): Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo. PubMed 35071493
- Gland Surg, 2020 (senior author): The relationship between central lymph node metastasis and the distance from tumor to thyroid capsule in papillary thyroid microcarcinoma without capsule invasion. PubMed 32775263
- Oncol Lett, 2019 (senior author): High PD-L1 expression is associated with a favorable prognosis in patients with esophageal squamous cell carcinoma undergoing postoperative adjuvant radiotherapy. PubMed 30675222
- Cancer Manag Res, 2018 (senior author): Multifocality is associated with central neck lymph node metastases in papillary thyroid microcarcinoma. PubMed 29942154
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion